Filing Details

Accession Number:
0001181431-12-052192
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-27 16:08:26
Reporting Period:
2012-09-25
Filing Date:
2012-09-27
Accepted Time:
2012-09-27 16:08:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1459450 Myrexis Inc. MYRX Pharmaceutical Preparations (2834) 263996918
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529269 Andrea Kendell C/O Myrexis, Inc.
305 Chipeta Way
Salt Lake City UT 84108
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-09-25 693 $2.34 33,094 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to an instruction given in accordance with Rule 10b5-1 by the Reporting Person on June 19, 2011, and was made to fund certain out-of-pocket tax withholding liabilities associated with the vesting of restricted stock units granted on September 24, 2010.